Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
APREAprea Therapeutics, Inc.
| Figure | APREAprea Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $12.60M |
| Net income, yoy | +2.8% |
| Net margin | — |
| Free cash flow | $13.57M |
| FCF margin | — |
| EPS, diluted | $1.93 |
Add another company.
Annual · USD
No annual figures on file for this.
From SEC EDGARSame fiscal periods, as filed